PCL Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 31

Employees

  • Stock Symbol
  • 241820

Stock Symbol

  • Share Price
  • $4.63
  • (As of Wednesday Closing)

PCL General Information

Description

PCL Inc is engaged in the development of vitro diagnostics products by SG Cap technology used in immobilizing disease biomarkers. It offers blood testing kit, multiplex antigen detection kits, and ultra-low volume non-contact liquid handling.In addition, the company offers platform services, such as sol-gel spotting service that immobilizes the customer's requested material using the SolB reagent; and SG ID service, which provides customers with a molecule of interest immobilized in the SolB reagent and identified.

Contact Information

Website
pclchip.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Room 701, Star Valley
  • 99, Digital-ro 9-gil, Geumcheon-gu
  • Seoul, 08510
  • South Korea
+82
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • Room 701, Star Valley
  • 99, Digital-ro 9-gil, Geumcheon-gu
  • Seoul, 08510
  • South Korea
+82

PCL Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PCL Stock Performance

As of 10-Sep-2025, PCL’s stock price is $4.63.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.63 $4.37 $4.30 - $21.24 2.78M 5.58K -$13.06

PCL Financials Summary

As of 30-Sep-2025, PCL has a trailing 12-month revenue of $3.53M.

In Thousands,
USD
TTM 30-Sep-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 26,379 147,640 137,159
Revenue 3,534 913 6,447 28,803
EBITDA (33,001) (36,387) (11,983) 1,103
Net Income (33,375) (38,359) (15,540) (3,109)
Total Assets 12,197 14,648 48,262 69,631
Total Debt 6,229 7,460 14,749 24,691
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PCL Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PCL‘s full profile, request access.

Request a free trial

PCL Patents

PCL Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022164214-A1 Apparatus and method for detecting spots within diagnostic kit result image Inactive 28-Jan-2021
WO-2022164215-A1 Device and method for diagnostic test using exclusion of atypical foreign material from test result image of artificial intelligence-based diagnostic kit Inactive 28-Jan-2021
JP-7650538-B2 A novel biomarker for diagnosing alzheimer's disease discovered from blood-derived exosomes and a method for diagnosing alzheimer's disease using the same Active 30-Nov-2020
JP-2023551327-A Novel alzheimer's disease diagnostic biomarker discovered from blood-derived exosomes and alzheimer's disease diagnostic method using the same Active 30-Nov-2020
DE-112021006226-T5 Novel biomarker for diagnosing alzheimer's disease discovered in a blood-derived exosome and method for diagnosing alzheimer's disease using the same Inactive 30-Nov-2020 G01N33/6896
To view PCL’s complete patent history, request access »

PCL Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PCL Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PCL‘s full profile, request access.

Request a free trial

PCL ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Technology Hardware

Industry

Rank

Percentile

Electronics Equipment

Subindustry

Rank

Percentile

To view PCL’s complete esg history, request access »

PCL FAQs

  • When was PCL founded?

    PCL was founded in 2008.

  • Where is PCL headquartered?

    PCL is headquartered in Seoul, South Korea.

  • What is the size of PCL?

    PCL has 31 total employees.

  • What industry is PCL in?

    PCL’s primary industry is Other Healthcare Technology Systems.

  • Is PCL a private or public company?

    PCL is a Public company.

  • What is PCL’s stock symbol?

    The ticker symbol for PCL is 241820.

  • What is the current stock price of PCL?

    As of 10-Sep-2025 the stock price of PCL is $4.63.

  • What is PCL’s current revenue?

    The trailing twelve month revenue for PCL is $3.53M.

  • What is PCL’s annual earnings per share (EPS)?

    PCL’s EPS for 12 months was -$13.06.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process